Clinical Trial Update: NIvolumab COmbination With Standard First-line Chemotherapy and Radiotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating nivolumab in combination with standard first-line chemotherapy and radiotherapy for locally advanced stage IIIA/B non-small cell lung…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: ETOP IBCSG Partners Foundation | Conditions: Non-small Cell Lung Cancer Stage III | Phase 2 | Status: COMPLETED | Results posted: 2021-10-25